Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2011 1
2012 1
2013 1
2014 6
2015 4
2016 4
2017 4
2019 1
2020 5
2021 5
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
Gallagher L, Xiao J, Hsueh J, Shah S, Danner M, Zwart A, Ayoob M, Yung T, Simpson T, Fallick M, Kumar D, Leger P, Dawson NA, Suy S, Collins SP. Gallagher L, et al. Among authors: yung t. Front Oncol. 2023 Oct 17;13:1289249. doi: 10.3389/fonc.2023.1289249. eCollection 2023. Front Oncol. 2023. PMID: 37916156 Free PMC article.
Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate Cancer.
Sholklapper T, Creswell M, Cantalino J, Markel M, Zwart A, Danner M, Ayoob M, Yung T, Collins B, Kumar D, Aghdam N, Rubin RS, Hankins R, Suy S, Collins S. Sholklapper T, et al. Among authors: yung t. J Sex Med. 2022 May;19(5):771-780. doi: 10.1016/j.jsxm.2022.02.018. Epub 2022 Mar 17. J Sex Med. 2022. PMID: 35305936
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
Sholklapper TN, Creswell ML, Payne AT, Markel M, Pepin A, Carrasquilla M, Zwart A, Danner M, Ayoob M, Yung T, Collins B, Kumar D, Aghdam N, Suy S, Hankins RA, Kowalczyk K, Collins SP. Sholklapper TN, et al. Among authors: yung t. Front Oncol. 2022 Mar 25;12:852844. doi: 10.3389/fonc.2022.852844. eCollection 2022. Front Oncol. 2022. PMID: 35402242 Free PMC article.
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S. Carrasquilla M, et al. Among authors: yung t. Front Oncol. 2023 Nov 23;13:1240939. doi: 10.3389/fonc.2023.1240939. eCollection 2023. Front Oncol. 2023. PMID: 38074646 Free PMC article.
The mechanisms of PML-nuclear body formation.
Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. Shen TH, et al. Among authors: yung tm. Mol Cell. 2006 Nov 3;24(3):331-9. doi: 10.1016/j.molcel.2006.09.013. Mol Cell. 2006. PMID: 17081985 Free PMC article.
Proctitis following stereotactic body radiation therapy for prostate cancer.
Joh DY, Chen LN, Porter G, Bhagat A, Sood S, Kim JS, Moures R, Yung T, Lei S, Collins BT, Ju AW, Suy S, Carroll J, Lynch JH, Dritschilo A, Collins SP. Joh DY, et al. Among authors: yung t. Radiat Oncol. 2014 Dec 12;9:277. doi: 10.1186/s13014-014-0277-4. Radiat Oncol. 2014. PMID: 25497602 Free PMC article.
40 results